Literature DB >> 17442378

Leprosy-specific B-cells within cellular infiltrates in active leprosy lesions.

Anand M Iyer1, Keshar K Mohanty, Danielle van Egmond, Kiran Katoch, William R Faber, Pranab K Das, Utpal Sengupta.   

Abstract

Leprosy is a spectral disease with polar lepromatous and tuberculoid forms correlating with enhanced humoral and cell-mediated immunity, respectively, against Mycobacterium leprae and the borderline forms, borderline lepromatous, midborderline, and borderline tuberculoid showing in-between clinical and immunological characteristics. Histopathologically, the cellular infiltrates of leprosy lesions show predominantly the presence of interacting T-cells and antigen presenting cells like macrophages, whereas the presence of B-cells has only been sporadically reported. The present study demonstrates by immunohistochemical techniques the presence of B-cells, including plasma cells, in active lesions from lepromatous leprosy, skin smear negative borderline lepromatous, and paucibacillary borderline tuberculoid leprosy. Furthermore, the study demonstrates the in situ production of M leprae-specific antibodies from BT lesions using an organotypic skin explant culture model. Finally, analysis of the cytokine release profile in supernatants of lesional organotypic skin cultures showed a microenvironment conducive to the differentiation and maturation of B-cells. The results demonstrate the presence of different functionally active B-cell stages within lesions of patients with leprosy, including borderline tuberculoid patients, which could secrete anti-M leprae-specific antibodies. However, their role in leprosy pathology remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442378     DOI: 10.1016/j.humpath.2006.12.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

2.  A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.

Authors:  Maria T Ochoa; Rosane Teles; Blake E Haas; Danny Zaghi; Huiying Li; Euzenir N Sarno; Thomas H Rea; Robert L Modlin; Delphine J Lee
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

3.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

4.  Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Authors:  A Iyer; M Hatta; R Usman; S Luiten; L Oskam; W Faber; A Geluk; P Das
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

5.  Immune Complex-Driven Generation of Human Macrophages with Anti-Inflammatory and Growth-Promoting Activity.

Authors:  Elizabeth Dalby; Stephen M Christensen; Jingya Wang; Kajal Hamidzadeh; Prabha Chandrasekaran; V Keith Hughitt; Wagner Luiz Tafuri; Rosa Maria Esteves Arantes; Ismael Alves Rodrigues; Ronald Herbst; Najib M El-Sayed; Gary P Sims; David M Mosser
Journal:  J Immunol       Date:  2020-05-20       Impact factor: 5.426

Review 6.  Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.

Authors:  Jorge Rodrigues de Sousa; Mirian Nacagami Sotto; Juarez Antonio Simões Quaresma
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

Review 7.  Human cutaneous B cells: what do we really know?

Authors:  Irina Lerman; Drew C Mitchell; Christopher T Richardson
Journal:  Ann Transl Med       Date:  2021-03

8.  The cellular architecture of the antimicrobial response network in human leprosy granulomas.

Authors:  Feiyang Ma; Travis K Hughes; Rosane M B Teles; Priscila R Andrade; Bruno J de Andrade Silva; Olesya Plazyo; Lam C Tsoi; Tran Do; Marc H Wadsworth; Aislyn Oulee; Maria Teresa Ochoa; Euzenir N Sarno; M Luisa Iruela-Arispe; Eynav Klechevsky; Bryan Bryson; Alex K Shalek; Barry R Bloom; Johann E Gudjonsson; Matteo Pellegrini; Robert L Modlin
Journal:  Nat Immunol       Date:  2021-06-24       Impact factor: 31.250

9.  Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?

Authors:  Ira Sharma; Avninder Singh; Ashwani K Mishra; L C Singh; V Ramesh; Sunita Saxena
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

10.  Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.

Authors:  Francianne M Amorim; Maurício L Nobre; Larissa S Nascimento; Alesson M Miranda; Glória R G Monteiro; Francisco P Freire-Neto; Maria do Carmo Palmeira Queiroz; José W Queiroz; Malcolm S Duthie; Marcos R Costa; Steven G Reed; Warren D Johnson; Kathryn M Dupnik; Selma M B Jeronimo
Journal:  PLoS Negl Trop Dis       Date:  2019-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.